biopharmaceutical | Business Facilities - Area Economic Development, Site Selection & Workforce Solutions

The German company, which operates its biopharm business as EMD Serono in the U.S. and Canada, will invest $70 million to expand its Billerica, MA facility.


https://businessfacilities.com/2019/02/merck-investing-70m-biopharm-rd-facility-expansion/
The German company, which operates its biopharm business as EMD Serono in the U.S. and Canada, will invest $70 million to expand its Billerica, MA facility.

biopharmaceutical

Economic development creates opportunities to grow state, local and metro areas, which are essential for economic growth, improved quality of life and community development. biopharmaceutical articles below.


Merck Investing $70M In Biopharm R&D Facility Expansion

The German company, which operates its biopharm business as EMD Serono in the U.S. and Canada, will invest $70 million to expand its Billerica, MA facility.

Merck Investing $49M In Asian Manufacturing, Distribution

Investment supports growing demand with new biopharmaceutical manufacturing and distribution centers in South Korea and India, accelerates biosimilars manufacturing and development in China.

Cook Pharmica Expanding in Monroe County, IN

Cook Pharmica, LLC plans to expand its biopharmaceutical development and manufacturing operations in Bloomington, IN, creating up to 70 new jobs by 2020.

Featured Location Spotlight

Location Spotlight: Topeka, Kansas

With three top universities in the area and connectivity via major interstates, Topeka, Kansas is rich with opportunity. Visit the GO Topeka Economic Partnership to learn more.

Featured Location Videos

Georgia Ports Authority: Garden City Terminal Expansion

At 1,200 acres, the Port of Savannah’s Garden City Terminal is North America’s largest single container terminal. Over the next decade, Georgia Ports Authority plans to expand the Port of Savannah’s annual capacity by 45 percent — from 5.5 million twenty-foot equivalent units to 8 million TEUs per year. Learn more.